Dibutyl sebacate

Suppliers

Names

[ CAS No. ]:
109-43-3

[ Name ]:
Dibutyl sebacate

[Synonym ]:
Sebacic Acid Dibutyl Ester
MFCD00001657
dibutyl ssebacate
dibutyl p-tolylphosphonate
sebacic acid di-n-butyl ester
dibutyl decanedioate
EINECS 207-395-0
Decanedioic Acid Dibutyl Ester
Di-n-butyl-sebacate
Dibutyl sebacate
Decanedioic acid, dibutyl ester
di-n-butyl sebacate
Dibutyl-p-tolylphosphit
p-Tolylphosphonsaeuredibutylester

Chemical & Physical Properties

[ Density]:
0.9±0.1 g/cm3

[ Boiling Point ]:
351.3±10.0 °C at 760 mmHg

[ Melting Point ]:
205 °C (dec.)(lit.)

[ Molecular Formula ]:
C18H34O4

[ Molecular Weight ]:
314.460

[ Flash Point ]:
157.5±17.4 °C

[ Exact Mass ]:
314.245697

[ PSA ]:
52.60000

[ LogP ]:
5.97

[ Vapour Pressure ]:
0.0±0.8 mmHg at 25°C

[ Index of Refraction ]:
1.448

[ Water Solubility ]:
hexane, toluene, ethanol and acetone: soluble

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VS1150000
CHEMICAL NAME :
Sebacic acid, dibutyl ester
CAS REGISTRY NUMBER :
109-43-3
BEILSTEIN REFERENCE NO. :
1798308
LAST UPDATED :
199710
DATA ITEMS CITED :
12
MOLECULAR FORMULA :
C18-H34-O4
MOLECULAR WEIGHT :
314.52
WISWESSER LINE NOTATION :
4OV8VO4

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
16 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NPIRI* Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. (National Assoc. of Printing Ink Research Institute, Francis McDonald Sinclair Memorial Laboratory, Lehigh Univ., Bethlehem, PA 18015) Volume(issue)/page/year: 2,22,1975
TYPE OF TEST :
LC - Lethal concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>5400 ug/m3/4H
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
GISAAA Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- Volume(issue)/page/year: 55(6),86,1990
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
19500 mg/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - other changes
REFERENCE :
GISAAA Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- Volume(issue)/page/year: 55(6),86,1990
TYPE OF TEST :
LC - Lethal concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>5400 ug/m3/2H
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
GISAAA Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- Volume(issue)/page/year: 55(6),86,1990
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
14700 uL/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JBMRBG Journal of Biomedical Materials Research. (John Wiley & Sons, Inc., 605 Third Ave., New York, NY 10158) V.1- 1967- Volume(issue)/page/year: 8,11,1974 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
418 gm/kg
SEX/DURATION :
male 10 week(s) pre-mating female 10 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
REFERENCE :
AMIHBC AMA Archives of Industrial Hygiene and Occupational Medicine. (Chicago, IL) V.2-10, 1950-54. For publisher information, see AEHLAU. Volume(issue)/page/year: 7,310,1953 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-RUSSIA:STEL 10 mg/m3 JAN 1993 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 84499 No. of Facilities: 67 (estimated) No. of Industries: 4 No. of Occupations: 10 No. of Employees: 2492 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 84499 No. of Facilities: 400 (estimated) No. of Industries: 4 No. of Occupations: 5 No. of Employees: 4856 (estimated) No. of Female Employees: 2157 (estimated)

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ Hazard Codes ]:
Xn,Xi

[ Risk Phrases ]:
R40:Limited evidence of a carcinogenic effect. R36/37/38:Irritating to eyes, respiratory system and skin .

[ Safety Phrases ]:
S36/37-S36-S26

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
VS1150000

[ HS Code ]:
2917131000

Synthetic Route

Precursor & DownStream

Precursor

  • Decanedioic acid
  • Butyl formate
  • Butanol
  • 1-Bromobutane
  • Sebacoyl chloride

DownStream

  • Hexachloroethane
  • 1,10-Decanediol
  • Decanedioic acid
  • Decanedioic acid hydrogen 1-butyl ester

Customs

[ HS Code ]: 2917131000

[ Summary ]:
2917131000 esters of adipic acid。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0%

Articles

A novel approach for honey pollen profile assessment using an electronic tongue and chemometric tools.

Anal. Chim. Acta 900 , 36-45, (2015)

Nowadays the main honey producing countries require accurate labeling of honey before commercialization, including floral classification. Traditionally, this classification is made by melissopalynolog...

Formulation considerations in the design of topical, polymeric film-forming systems for sustained drug delivery to the skin.

Eur. J. Pharm. Biopharm. 91 , 9-15, (2015)

Polymeric film-forming systems (FFSs) are potential drug delivery systems for topical application to the skin. The FFSs form thin and transparent polymeric films in situ upon solvent evaporation. Thei...

In-line NIR monitoring of key characteristics of enteric coated pellets.

Eur. J. Pharm. Biopharm. 88(3) , 847-55, (2015)

We describe the development of an in-line monitoring approach for the fluid-bed drying and coating steps for the production of enteric coated pellets by NIR. Our results show that key pellet character...


More Articles


Related Compounds

  • dibutyl-mercapto-borane
  • dibutyl-methyl-(3-methylphenoxy)silane
  • dibutyl tetrasulfide
  • dibutyl tin dioleate
  • dibutyl-p-styryltin di-t-butylphosphine
  • dibutyl (6-methyl-2-propan-2-ylpyrimidin-4-yl) phosphate
  • (2S)-6-Methylheptane-2,5-diol
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • (2,3-dimethoxyphenyl)(4-(1-methyl-1H-imidazol-2-yl)piperazin-1-yl)methanone hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • 1-(4-(((4,5-Dihydrothiazol-2-yl)thio)methyl)piperidin-1-yl)-2-(2-fluorophenoxy)ethanone
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 9-Chloro-8-methoxy-1,2,3,4-tetrahydro-benzo[B]azepin-5-one